![](/img/cover-not-exists.png)
A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial
Fuchs, C. S., Azevedo, S., Okusaka, T., Van Laethem, J.- L., Lipton, L. R., Riess, H., Szczylik, C., Moore, M. J., Peeters, M., Bodoky, G., Ikeda, M., Melichar, B., Nemecek, R., Ohkawa, S., wieboda-SVolume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv027
Date:
May, 2015
File:
PDF, 210 KB
english, 2015